Health

Bipartisan vote moves forward a bill repealing Obamacare’s Medicare cost-cutting body.

The FDA’s proposal to modernize generic drug approvals meets with broad support.

New bill would allow manufacturers of certain medical device to bypass elements of FDA’s existing process.

Despite political assurances, nothing has changed legally in the contraceptive insurance controversy.

Agency recommends statutory language for imposing user fees on biosimilar drug manufacturers.

The FDA cautions patients to undergo only approved stem cell treatments.

Regulatory conference highlights need for defined governance of laboratory developed diagnostic testing.

Guidelines require more vegetables, less fat.

The USDA would inspect operations while decreasing its focus on expensive slaughter line inspections.

Affordable Care Act requires approval of insurance company rate hikes for individual and small group plans.

Statutory change will ease medical training and health care delivery by the Department of Defense.

Federal government should fund research using stem cells from unfertilized eggs.